Observational studyClinical rheumatology2017

Maintenance of efficacy and safety with subcutaneous golimumab in rheumatoid arthritis patients with low disease activity who previously received TNF inhibitors.

Hiroki Wakabayashi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.